[Evaluation in vivo of the hydaluronidase activity of a substance by means of the cutaneous clearance of a radioactive tracer. Determination of the hydaluronidase activity in combination with equal parts of 2-(beta-chloroethyl)-2,3-dihydro-4-hydroxy-(benzo-1,3-oxazine) and 1,4-diphenyl-3,5-dihydroxypyrazolidine].
D000700:Analgesics; D018712:Analgesics, Non-Narcotic / Q000737:chemistry*; D058633:Antipyretics; D001713:Biphenyl Compounds; D004155:Diphenhydramine; D006821:Hyaluronoglucosaminidase / Q000737:chemistry*; D010078:Oxazines; D011849:Radioactive Tracers
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001713:Biphenyl Compounds; D004155:Diphenhydramine; D006821:Hyaluronoglucosaminidase; D010078:Oxazines; D011849:Radioactive Tracers; C010574:biphenyl
ANALGESICS AND ANTIPYRETICS/chemistry; HYALURONIDASE/chemistry